17 results
10-K
2023 FY
SLRN
Acelyrin Inc
28 Mar 24
Annual report
4:21pm
attacks by computer hackers, cracking, application security attacks, social engineering (including through deep fakes, which may be increasingly more
8-K
EX-99.3
SLRN
Acelyrin Inc
11 Mar 24
ACELYRIN, INC. Announces Positive Top-line Results from Its Global Phase 2b/3 Clinical Trial of Izokibep in Psoriatic Arthritis
8:05am
abscesses, inflammatory nodules, fistulae, scar tissue, malodor and pain, often resulting in permanent disfigurement and social stigma negatively impacting
10-Q
sbz1a05lzuj865ybc
15 Jun 23
Quarterly report
4:19pm
424B4
a7pci9
5 May 23
Prospectus supplement with pricing info
4:22pm
S-1/A
zukijm
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.6
m4hiaf7c416l7qf4 m95
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-10.3
04lm29h8svsalglq
1 May 23
IPO registration (amended)
6:10am
S-1/A
EX-4.1
uc5rzgzwz
1 May 23
IPO registration (amended)
6:10am
S-1
EX-10.12
82841d1hurfdef6u154w
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.13
d1lp9a
13 Apr 23
IPO registration
5:10pm
S-1
EX-2.1
dy4z85i
13 Apr 23
IPO registration
5:10pm
S-1
EX-10.2
51zqqfmk6x0uzmq1hxyk
13 Apr 23
IPO registration
5:10pm
S-1
82vrt
13 Apr 23
IPO registration
5:10pm
- Prev
- 1
- Next